Capsular sialic acid limits C5a production on type III group B streptococci (Q34000922)

30 July 2017

title

Capsular sialic acid limits C5a production on type III group B streptococci (English)

1 reference

30 July 2017

S Takahashi

1

1 reference

30 July 2017

Y Aoyagi

2

1 reference

30 July 2017

E E Adderson

3

1 reference

30 July 2017

Y Okuwaki

4

1 reference

30 July 2017

J F Bohnsack

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

30 July 2017

published in

Infection and Immunity

1 reference

30 July 2017

volume

67

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

1866-1870

1 reference

Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96539

Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96539

Role of C5a-ase in group B streptococcal resistance to opsonophagocytic killing

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96539

Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96539

Protection of mice from experimental infection with type III group B Streptococcus using monoclonal antibodies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96539

The isolation of IgG from mammalian sera with the aid of caprylic acid

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96539

Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96539

Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=96539

Group B streptococci inhibit the chemotactic activity of the fifth component of complement

5 July 2018

1 reference

12 December 2020

Restriction endonuclease digest patterns of chromosomal DNA from group B -haemolytic streptococci

1 reference

12 December 2020

Invasive group B streptococcal disease: the emergence of serotype V

1 reference

12 December 2020

Structural and immunochemical characterization of the type VIII group B Streptococcus capsular polysaccharide

1 reference

12 December 2020

A role for C5 and C5a-ase in the acute neutrophil response to group B streptococcal infections

1 reference

12 December 2020

Identification of a highly encapsulated, genetically related group of invasive type III group B streptococci

1 reference

12 December 2020

Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci

1 reference

12 December 2020

Identifiers

PMC publication ID

96539

1 reference

30 July 2017

1 reference